Annual Current Liabilities
$4.19 M
+$984.10 K+30.68%
31 December 2023
Summary:
Context Therapeutics annual total current liabilities is currently $4.19 million, with the most recent change of +$984.10 thousand (+30.68%) on 31 December 2023. During the last 3 years, it has fallen by -$5.36 million (-56.10%). CNTX annual current liabilities is now -82.61% below its all-time high of $24.11 million, reached on 31 December 2019.CNTX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$2.33 M
+$727.70 K+45.36%
01 September 2024
Summary:
Context Therapeutics quarterly total current liabilities is currently $2.33 million, with the most recent change of +$727.70 thousand (+45.36%) on 01 September 2024. Over the past year, it has dropped by -$2.27 million (-49.35%). CNTX quarterly current liabilities is now -75.58% below its all-time high of $9.55 million, reached on 31 December 2020.CNTX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNTX Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +30.7% | -49.4% |
| 3 y3 years | -56.1% | -47.1% |
| 5 y5 years | - | - |
CNTX Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -56.1% | +38.2% | -49.4% | +45.4% |
| 5 y | 5 years | -82.6% | +38.2% | -75.6% | +45.4% |
| alltime | all time | -82.6% | +38.2% | -75.6% | +45.4% |
Context Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.33 M(+45.4%) |
| June 2024 | - | $1.60 M(-38.5%) |
| Mar 2024 | - | $2.61 M(-37.8%) |
| Dec 2023 | $4.19 M(+30.7%) | $4.19 M(-9.0%) |
| Sept 2023 | - | $4.60 M(+22.5%) |
| June 2023 | - | $3.76 M(+16.2%) |
| Mar 2023 | - | $3.23 M(+0.8%) |
| Dec 2022 | $3.21 M | $3.21 M(-20.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $4.01 M(+32.0%) |
| June 2022 | - | $3.04 M(+89.2%) |
| Mar 2022 | - | $1.61 M(-47.0%) |
| Dec 2021 | $3.03 M(-68.2%) | $3.03 M(-31.2%) |
| Sept 2021 | - | $4.41 M(+11.3%) |
| June 2021 | - | $3.96 M(+18.6%) |
| Mar 2021 | - | $3.34 M(-65.0%) |
| Dec 2020 | $9.55 M(-60.4%) | $9.55 M |
| Dec 2019 | $24.11 M | - |
FAQ
- What is Context Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Context Therapeutics?
- What is Context Therapeutics annual current liabilities year-on-year change?
- What is Context Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Context Therapeutics?
- What is Context Therapeutics quarterly current liabilities year-on-year change?
What is Context Therapeutics annual total current liabilities?
The current annual current liabilities of CNTX is $4.19 M
What is the all time high annual current liabilities for Context Therapeutics?
Context Therapeutics all-time high annual total current liabilities is $24.11 M
What is Context Therapeutics annual current liabilities year-on-year change?
Over the past year, CNTX annual total current liabilities has changed by +$984.10 K (+30.68%)
What is Context Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of CNTX is $2.33 M
What is the all time high quarterly current liabilities for Context Therapeutics?
Context Therapeutics all-time high quarterly total current liabilities is $9.55 M
What is Context Therapeutics quarterly current liabilities year-on-year change?
Over the past year, CNTX quarterly total current liabilities has changed by -$2.27 M (-49.35%)